Cowen, Piper Jaffray, Nomura and Wedbush PacGrow assist with deal
By Angela McDaniels
Tacoma, Wash., Nov. 10 – Voyager Therapeutics, Inc. is selling 5 million shares of common stock for $14.00 each in its initial public offering for a total of $70 million. There is a $10.5 million greenshoe.
The company initially planned to sell 4,687,500 shares for between $15.00 and $17.00 each.
Cowen and Co. and Piper Jaffray are the bookrunners, and Wedbush PacGrow and Nomura are the co-managers.
Proceeds will be used for clinical development, clinical trials, preclinical development, working capital and other general corporate purposes.
The clinical-stage gene therapy company is based in Cambridge, Mass. The company expects its stock to begin trading on the Nasdaq Global Select Market on Nov. 11 under the symbol “VYGR.”
| Issuer: | Voyager Therapeutics, Inc.
|
| Issue: | Common stock
|
| Amount: | $70 million
|
| Greenshoe: | $10.5 million
|
| Shares: | 5 million
|
| Price: | $14.00
|
| Warrants: | No
|
| Bookrunners: | Cowen and Co. and Piper Jaffray & Co.
|
| Co-managers: | Wedbush PacGrow and Nomura
|
| Pricing date: | Nov. 10
|
| Settlement date: | Nov. 16
|
| Expected listing: | Nasdaq: VYGR
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
